GE HealthCare (Nasdaq: GEHC) + today announced the launch of its “new era” of AI-enhanced oncology solutions, known as Revolution RT.
Revolution RT is a new radiation therapy computed tomography (CT) solution with innovative hardware and software solutions to increase imaging accuracy and simplify simulation workflow. The Chicago-based company designed the technology to create a more personalized and seamless oncology care pathway experience for clinicians and patients. The technology was showcased at the European Society for Therapeutic Radiology and Oncology 2024 Congress in Glasgow, Scotland.
The company also launched an updated and artificial intelligence (AI)-enhanced version of the Intelligent Radiation Therapy Platform (iRT) that interfaces with the Spectronic magnetic resonance imaging Planner.
“At GE HealthCare, we are committed to advancing the frontiers of oncology treatment through AI-dri…